Polymorph confirmation at lab scale does not guarantee process robustness. When alternative forms exist within a narrow stability window (<1 kcal/mol), competitive behavior may emerge under:
This can result in:
Solid-form robustness is a development variable — not just a discovery observation..
Our program goes beyond risk identification. We provide structured engineering insight:
Turnaround: 2–3 weeks
Designed for milestone-aligned decision-making.

If your team is advancing a small-molecule asset toward clinical expansion or manufacturing scale-up, we would be glad to review your development context. Contact: wayne.wang@agilgen.com
Today | Closed |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.